Literature DB >> 118968

Isolation and characterization of antithrombin III from human, porcine and rabbit plasma, and rat serum.

T Koide.   

Abstract

1. Human, porcine, rabbit, and rat antithrombin III have been purified by affinity chromatography using heparin-agarose. The amino acid and carbohydrate compositions, amino-terminal sequences, immunological cross-reactivities, and inhibitions of human thrombin were studied. 2. Human, porcine, rabbit, and rat antithrombin III are single-chain glycoproteins containing hexose, glucosamine, and neuraminic acid. 3. The total carbohydrate contents were 17, 16, 14, and 15% for human, porcine, rabbit, and rat antithrombin III, respectively. 4. Molecular weights estimated from the migration in sodium dodecyl sulfate (SDS)-poly-acrylamide gel electrophoresis were 59,000, 58,000, 63,000, and 63,000 for human, porcine rabbit, and rat antithrombin III, respectively. 5. These four proteins have similar amino acid compositions, although some minor differences were noted. 6. Human, porcine, and rabbit antithrombin III have a histidine residue at the amino-terminus, while rat antithrombin III contains an amino-terminal asparagine residue. 7. The amino-terminal sequences up to the first 17 residues showed high homology among the four proteins. 8. Some immunological cross-reactivity was observed only between human and porcine antithrombin III. 9. The apparent dissociation constants (KI) for the complexes between human thrombin and human, porcine, rabbit, and rat antithrombin III were about 1.2 x 10(-10) M, 9.5 X 10 (-9) M, 1.4 X 10(-7) M, and 2.8 X 10(-9) M, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 118968     DOI: 10.1093/oxfordjournals.jbchem.a132706

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Re-formation of disulphide bonds in reduced antithrombin III.

Authors:  X J Sun; J Y Chang
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

2.  The C-terminal sequence of human and porcine antithrombin III and its homology with human alpha-1-proteinase inhibitor.

Authors:  T Koide; Y Ohta; T Ono
Journal:  Experientia       Date:  1980-05-15

Review 3.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

4.  Isolation and properties of two forms of thrombin inhibitor from the nymphs of the camel tick Hyalomma dromedarii (Acari: Ixodidae).

Authors:  M A Ibrahim; A H Ghazy; T Maharem; M Khalil
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

5.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Authors:  T Koide; S Odani; K Takahashi; T Ono; N Sakuragawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

6.  Protective effect of antithrombin III in acute experimental pancreatitis in rats.

Authors:  W K Bleeker; J Agterberg; G Rigter; C E Hack; J V Gool
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

7.  Antithrombin III (AT3) polymorphism in the marsupial Monodelphis domestica: identification and genetics.

Authors:  K Bell; H Arthur; R A van Oorschot; J L VandeBerg
Journal:  Biochem Genet       Date:  1992-12       Impact factor: 1.890

8.  An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome.

Authors:  Shigeatsu Endo; Ryutaro Shimazaki
Journal:  J Intensive Care       Date:  2018-11-16

Review 9.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.